Anees Ashika, Panicker Praveen, Iype Thomas, Sreelekha K R
Department of Neurology, Government Medical College Thiruvananthapuram, Kerala, India.
Department of Community Medicine, Government Medical College Thiruvananthapuram, Kerala, India.
J Neurosci Rural Pract. 2024 Jan-Mar;15(1):86-94. doi: 10.25259/JNRP_325_2023. Epub 2023 Jul 14.
Intravenous thrombolysis is an effective treatment of acute ischemic stroke but has a narrow therapeutic time window of 3-4.5 h. Pre-hospital delay is a major barrier to patients becoming eligible for thrombolysis. This single-center study assessed the factors causing longer onset-to-door (OTD) time to identify measures that will help decrease the delay.
Patients with acute ischemic stroke presenting to the emergency department from August to October 2022 were included in the study. The data were collected using a structured questionnaire and was completed by interviewing the patient or the caregivers. Patients were classified as early and late arrivers with the cutoff being 3.5 h. We then analyzed the relationship between early arrival and demographic factors, clinical factors, patient response factors, and logistic factors.
Our study consisted of 153 patients. The average OTD time was 674.33 ± 812.713 min (median: 300; interquartile range: 151-885). The pre-hospital delay was present in 66% of patients. 16.9% of patients came beyond 24 h. In the multivariate analysis, the odds of early arrival were higher among patients who perceived their symptoms as serious (odds ratio [OR]: 18.801; confidence interval [CI]: 3.728-94.803) and lower among patients who experienced a delay in reaching due to traffic (OR: 0.085; CI: 0.008-0.873). Lack of knowledge about stroke centers among both patients and health professionals also contributed to longer OTD times. Out of 52 early arrivers, 24 received thrombolytic therapy after excluding wake-up strokes and contraindications.
Pre-hospital delay continues to stand in the way of patients receiving thrombolysis. Comprehensive stroke education, increasing awareness regarding stroke centers, and promoting ambulance services are some of the interventions which could help tackle the issue.
静脉溶栓是治疗急性缺血性卒中的有效方法,但治疗时间窗狭窄,为3 - 4.5小时。院前延误是患者无法接受溶栓治疗的主要障碍。这项单中心研究评估了导致发病至入院(OTD)时间延长的因素,以确定有助于减少延误的措施。
纳入2022年8月至10月到急诊科就诊的急性缺血性卒中患者。数据通过结构化问卷收集,通过询问患者或护理人员完成。患者被分为早到者和晚到者,分界点为3.5小时。然后我们分析了早到与人口统计学因素、临床因素、患者反应因素和后勤因素之间的关系。
我们的研究包括153名患者。平均OTD时间为674.33±812.713分钟(中位数:300;四分位间距:151 - 885)。66%的患者存在院前延误。16.9%的患者在发病24小时后才到达。在多因素分析中,认为自己症状严重的患者早到的几率更高(比值比[OR]:18.801;置信区间[CI]:3.728 - 94.803),因交通延误而到达较晚的患者早到几率较低(OR:0.085;CI:0.008 - 0.873)。患者和医护人员对卒中中心缺乏了解也导致OTD时间延长。在52名早到者中,排除醒后卒中及禁忌证后,24名接受了溶栓治疗。
院前延误仍然阻碍着患者接受溶栓治疗。全面的卒中教育、提高对卒中中心的认识以及推广救护车服务是有助于解决这一问题的一些干预措施。